Ten years ago, the U.S. Agency for International Development unveiled the largest project in its history, hoping it would revolutionize health supply chains around the world to such an extent that it would be the last such contract of its kind. Devex Senior Reporter Michael Igoe details how these hopes were dashed in an investigative report that was the subject of the latest edition of the This Week in Global Development podcast. Speaking to Devex Editor-in-Chief Raj Kumar and Fatema Sumar of Harvard’s Center for International Development, Igoe pulls back the curtain on the $9.5 billion contract, which was led by U.S.-based behemoth Chemonics International. His report — done in conjunction with the Bureau of Investigative Journalism — chronicles the early failings of the supply chain project, including a low point when a dismal 7% of shipments arrived at their destinations on time, forcing multiple countries to scramble as they ran short of lifesaving health products ranging from HIV/AIDS drugs to mosquito nets. The three speakers also discussed the nuances of aid spending to curb migration and the progress — or lack thereof, depending on your perspective — of the hotly debated loss and damage fund to compensate vulnerable countries for the effects of climate change. Sign up to the Devex Newswire and our other newsletters.